Avalyn Pharma Inc.
AVLN
$38.72
$2.145.84%
NASDAQ
| 06/30/2026 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 186.23% | -- | |||
| Total Receivables | 561.66% | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 86.11% | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -60.28% | -- | |||
| Total Current Assets | 175.40% | -- | |||
|
|
|||||
| Total Current Assets | 175.40% | -- | |||
| Net Property, Plant & Equipment | 24.99% | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 0.40% | -- | |||
| Total Assets | 213.61% | -- | |||
|
|
|||||
| Total Accounts Payable | -15.86% | -- | |||
| Total Accrued Expenses | -9.69% | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 60.95% | -- | |||
| Total Finance Division Other Current Liabilities | -- | -- | |||
| Total Other Current Liabilities | -- | -- | |||
| Total Current Liabilities | -8.30% | -- | |||
|
|
|||||
| Total Current Liabilities | -8.30% | -- | |||
| Long-Term Debt | -0.05% | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | 36.63% | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | -2.11% | -- | |||
|
|
|||||
| Common Stock & APIC | 2,472.42% | -- | |||
| Retained Earnings | -9.90% | -- | |||
| Treasury Stock & Other | -891.67% | -- | |||
| Total Common Equity | 250.75% | -- | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | 250.75% | -- | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 268.92% | -- | |||
|
|
|||||